Form 8-K - Current report:
SEC Accession No. 0001654954-17-004080
Filing Date
2017-05-05
Accepted
2017-05-05 07:35:08
Documents
2
Period of Report
2017-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx8-kreresultsofoperati.htm 8-K 26815
2 EXHIBIT 99.1 v439471_ex99-1.htm EX-99.1 85865
  Complete submission text file 0001654954-17-004080.txt   114086
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 17816089
SIC: 2834 Pharmaceutical Preparations